Page last updated: 2024-10-30

lomustine and MS (Multiple Sclerosis)

lomustine has been researched along with MS (Multiple Sclerosis) in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Cyclophosphamide (CY), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 5-fluorouracil (5-FU) were given in single course schedules to chronic progressive multiple sclerosis (MS) patients clinically stable for 6 months."3.66Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis. ( Baumhefner, RW; Fahey, JL; Haskell, CM; Korn, EL; Shih, WW; Tourtellotte, WW, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shih, WW1
Baumhefner, RW1
Tourtellotte, WW1
Haskell, CM1
Korn, EL1
Fahey, JL1

Other Studies

1 other study available for lomustine and MS (Multiple Sclerosis)

ArticleYear
Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis.
    Clinical and experimental immunology, 1983, Volume: 53, Issue:1

    Topics: Adult; Cyclophosphamide; Fluorouracil; Humans; Immunoglobulin G; Killer Cells, Natural; Leukocyte Co

1983